Clin2
NCT06549504Possibly a fitNot yet recruiting

Bioequivalence study of AG2202

Bioequivalence Study

This trial tests whether a new version of a drug (AG2202) works the same way in the body as the original. It is for healthy volunteers to check how the drug is absorbed and processed.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
34 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are 19 years old or older.
  • Your BMI (body mass index) is between 18.0 and 30.0.
  • You are generally healthy with no significant ongoing illnesses.
  • You have not taken certain drugs that affect liver enzymes in the last 30 days, or drugs that might interact with the study drug in the last 10 days.
  • You have not taken this investigational drug in the last 6 months.
  • You have not donated blood (whole blood in the last 8 weeks, or blood components like plasma in the last 2 weeks) or received a blood transfusion in the last 4 weeks.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06916169Not yet recruiting· Phase 1
Testing a new combination drug in healthy adults

This trial tests a new combination drug (AG2304) compared to taking two separate drugs together. It's for healthy adults to see how the body handles the drugs and check for safety.

NCT07715305Not yet recruiting· Phase 1
Bioequivalence study of two drug forms in healthy men

This trial tests whether two versions of a drug, AD-116A and AD-1161, are equally effective and safe in the body. Healthy adult male volunteers take the drug and have their blood levels compared.

Seoul
NCT07581028Not yet recruiting· Phase 1
Comparing Two Versions of an Experimental Drug in Healthy Adults

This study tests whether two different formulations of an experimental medication (AJU-C715) work the same way in your body. Researchers will give you one version and then later the other version to compare how much of the drug enters your bloodstream and how long it stays there.

Seoul
NCT07144176Recruiting· Phase 1
Comparing two drugs in healthy volunteers

This trial compares two similar drugs (DWJ1511 and DWC202501) to see how they are processed by the body and how safe they are. It is for healthy volunteers to help ensure the drugs work the same way.

Seoul
NCT07526116Recruiting· Phase 1
Safety study of REGN22044 in healthy adults

This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.

Ghent, Oost-Vlaanderen
NCT07727629Not yet recruiting· Phase 1
Comparing two drug versions in healthy volunteers

This trial tests two versions of the same drug to see if they work the same in the body. It's for healthy volunteers who are willing to follow strict guidelines about diet, exercise, and medications.

Cheongju-si, North Chungcheong

Hear when a new Bioequivalence Study trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.